18th Annual International Congress on Hematologic Malignancies®
Crowne Plaza
New York, NY
February 14 - 15, 2014
 
31st Annual Miami Breast Cancer Conference®
Fontainebleau Miami Beach
Miami Beach, FL
March 6 - 9, 2014
 
7th Annual Interdisciplinary Prostate Cancer Congress™ (IPCC®)
Corwne Plaza 
New York, NY
March 15, 2014
 
13th Annual International Congress on the Future of Breast Cancer®
Hyatt Regency
Huntington Beach, CA
July 17 - 19, 2014
 
15th Annual International Lung Cancer Congress®
Hyatt Regency
Huntington Beach, CA
July 31 - August 2, 2014

12th Annual International Congress on Targeted Therapies in Cancer®
New York, NY
October 2014

12th Annual School of Breast Oncology®
Emory University Conference Center
Atlanta, GA

November 6 - 9, 2014

9th Annual New York Lung Cancer Symposium®
New York
November 8, 2014




Upcoming AJMC events
With the fast moving, ever-changing landscape of healthcare today, the mission of AJMC TV is to inform payers, clinical decision makers, and policy makers through brief video interviews providing the most recent and important information.
Edmund J. Pezalla, MD, MPH, Describes Aetna’s Approach to Managing Obesity
Edmund J. Pezalla, MD, MPH, national medical director, Aetna Pharmacy Management, says that Aetna recognizes the implications of the obesity epidemic and how it contributes to a variety of other medical problems such as diabetes and hypertension.
 
Christine Strahl, PharmD, MBA, BCPS, Discusses Channels and Methods for Specialty Pharmacy Distribution
Christine Strahl, PharmD, MBA, BCPS, specialty pharmacy program manager, HealthPartners, says there are several new distribution channels in specialty pharmacy.
 
Amy Tenderich Explains the Value of Patient-Centered Diabetes Care
Amy Tenderich of DiabetesMine.com, a web-based news source for persons with diabetes, took part in panel discussions at “Patient-Centered Diabetes Care: Putting Theory into Practice,” sponsored by The American Journal of Managed Care.
Episdoe 9 - Benefit Design and Making Treatment Affordable
Dr Dunn introduces the discussion of benefit design, suggesting that managed care providers may be unprepared to administer specialty drugs.